Skip to content
effecthub

OpenEvidence vs Statim

Two fact sheets from our own research, side by side — pricing, platforms, API access and status re-checked by us rather than quoted from the vendors.

The short answer

Free plan
Both are free to use
Higher Trust score
OpenEvidence — 91 vs 78 for Statim
Best fit
OpenEvidence: US physicians, NPs and PAs who want cited point-of-care answers instead of a general chatbot · Statim: Clinical pharmacists checking adverse-event and off-label data quickly
Platforms
OpenEvidence: Web, iOS, Android · Statim: Web
Status
We could not check OpenEvidence — its site turns automated checks away; Statim was up on Oct 14, 2026

From our own records as of each tool's last check. Anything we have not confirmed is left out rather than guessed. How we verify

Side by side

FactOpenEvidenceStatim
CategoryHealthcare & MedicalHealthcare & Medical
Pricing modelFreeFree
Trust score91 / 10078 / 100
PlatformsWeb, iOS, AndroidWeb
CompanyOpenEvidence Inc.Statim
Last verifiedSep 6, 2026Oct 14, 2026

What our research says

OpenEvidence

For a US clinician this is the obvious free alternative to a general chatbot: the answers cite the journals you would cite yourself, the licensed NEJM and JAMA text is something ChatGPT cannot legally see, and it costs nothing. The trade is that the business model is pharmaceutical advertising inside a clinical tool, and the service is closed to everyone without a US professional identifier.

Pros

  • Every claim carries a citation, with licensed full text from NEJM, JAMA, Nature and Cochrane rather than abstracts
  • Free with no paid tier, and CME credit accrues from ordinary use
  • Evidence grading shows how strong the support for an answer is
  • Mobile apps add ambient documentation and voice mode for use during consultations

Cons

  • Revenue is pharmaceutical advertising placed next to clinical answers, a conflict worth keeping in view
  • US-only verification shuts out clinicians elsewhere, and the guideline corpus leans US practice
  • The site refuses automated access and the vendor publishes little about accuracy on complex cases
  • No API or integration path for health systems that want it inside the EHR

Statim

Statim packages several separate lookups — drug label, adverse events, trial data — into one searchable workspace instead of making clinicians check FDA, PubMed, and ClinicalTrials.gov one at a time. Being completely free is the strongest and strangest part of the pitch: there's no visible revenue model, so it's worth treating this as an early-stage or subsidized project rather than an established reference tool.

Pros

  • Combines drug label, FDA adverse-event, and trial data in one search
  • Cites sources like PubMed and ClinicalTrials.gov for its answers
  • No cost and no account tier restrictions found on the site

Cons

  • No stated business model, which raises questions about long-term availability
  • Launch date and company size are not disclosed
  • Independent, non-pharma-affiliated status is a self-description, not third-party verified

Which one fits

Choose OpenEvidence if you need

  • US physicians, NPs and PAs who want cited point-of-care answers instead of a general chatbot
  • Residents and trainees who want CME credit and evidence grading built into the lookup
  • Clinicians who need the licensed full text of NEJM and JAMA articles in the answer

Choose Statim if you need

  • Clinical pharmacists checking adverse-event and off-label data quickly
  • Medical students and residents cross-referencing trial evidence against labels
  • Specialist physicians who want citations alongside a drug answer

OpenEvidence vs Statim: the questions people ask

Does OpenEvidence or Statim have a free tier?

Both: OpenEvidence is free to use, and Statim is free to use.

Browse all Healthcare & Medical →